The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid Cancer

Farnaz Nesari Javan1, Emran Askari1, Susan Shafiei1

  • 1Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

Preablation stimulated thyroglobulin (psTg) levels predict treatment outcomes in pediatric differentiated thyroid carcinoma (DTC). Elevated psTg (≥ 13.75 ng/mL) is the strongest indicator of incomplete initial response and predicts distant metastases in children with DTC.

Area of Science:

  • Pediatric Endocrinology
  • Oncology
  • Nuclear Medicine

Background:

  • Differentiated thyroid carcinoma (DTC) is the most common endocrine malignancy in children.
  • Identifying prognostic factors is crucial for optimizing treatment strategies and improving outcomes in pediatric DTC patients.
  • Long-term follow-up is essential for assessing treatment response and detecting recurrence.

Purpose of the Study:

  • To identify prognostic factors influencing treatment outcomes in children with DTC.
  • To analyze the predictive value of preablation stimulated thyroglobulin (psTg) levels.
  • To evaluate the relationship between psTg levels and treatment response, including distant metastasis.

Main Methods:

  • Retrospective analysis of 126 children (≤18 years) treated for DTC over 27 years.
  • All patients underwent near-total thyroidectomy, radioiodine therapy, and thyroid hormone replacement.
  • Follow-up included clinical evaluation and biochemical markers (psTg) according to American Thyroid Association guidelines.

Main Results:

  • Papillary thyroid cancer predominated (93.7%); 52.4% had lymph node metastasis, and 8.8% had distant metastasis.
  • Preablation stimulated thyroglobulin (psTg) levels were significantly higher in patients with incomplete first-year response (202.4 ng/mL vs. 11.2 ng/mL, P=.001).
  • Logistic regression identified psTg as the sole significant predictor of distant metastasis, with psTg ≥ 13.75 ng/mL being the strongest predictor of incomplete initial response.

Conclusions:

  • Preablation stimulated thyroglobulin (psTg) level is the most significant predictor of distant metastases in pediatric differentiated thyroid carcinoma.
  • A psTg level ≥ 13.75 ng/mL is the most powerful indicator of an incomplete treatment response within the first year.
  • These findings emphasize the importance of psTg monitoring for risk stratification and treatment management in children with DTC.
Abstract